Figure 2From: A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia Median plasma concentration-time profiles of paliperidone (data from 212 patients). Time-concentration profiles were based on data from 212 patients.Back to article page